123 related articles for article (PubMed ID: 7720880)
1. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution.
Pereira FB; Goñi FM; Nieva JL
FEBS Lett; 1995 Apr; 362(2):243-6. PubMed ID: 7720880
[TBL] [Abstract][Full Text] [Related]
2. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
Pritsker M; Jones P; Blumenthal R; Shai Y
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
[TBL] [Abstract][Full Text] [Related]
3. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Pereira FB; Goñi FM; Muga A; Nieva JL
Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.
Nieva JL; Nir S; Muga A; Goñi FM; Wilschut J
Biochemistry; 1994 Mar; 33(11):3201-9. PubMed ID: 8136355
[TBL] [Abstract][Full Text] [Related]
5. Membrane fusion induced by the HIV type 1 fusion peptide: modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds.
Pereira FB; Goñi FM; Nieva JL
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1203-11. PubMed ID: 9310287
[TBL] [Abstract][Full Text] [Related]
6. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
Suárez T; Nir S; Goñi FM; Saéz-Cirión A; Nieva JL
FEBS Lett; 2000 Jul; 477(1-2):145-9. PubMed ID: 10899326
[TBL] [Abstract][Full Text] [Related]
7. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.
Kliger Y; Aharoni A; Rapaport D; Jones P; Blumenthal R; Shai Y
J Biol Chem; 1997 May; 272(21):13496-505. PubMed ID: 9153194
[TBL] [Abstract][Full Text] [Related]
8. Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion.
Haque ME; Lentz BR
Biochemistry; 2002 Sep; 41(35):10866-76. PubMed ID: 12196026
[TBL] [Abstract][Full Text] [Related]
9. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
[TBL] [Abstract][Full Text] [Related]
10. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
Jiang S; Lin K
Pept Res; 1995; 8(6):345-8. PubMed ID: 8838418
[TBL] [Abstract][Full Text] [Related]
11. Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism.
Contreras LM; Aranda FJ; Gavilanes F; González-Ros JM; Villalaín J
Biochemistry; 2001 Mar; 40(10):3196-207. PubMed ID: 11258936
[TBL] [Abstract][Full Text] [Related]
12. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
13. Multimerized CHR-derived peptides as HIV-1 fusion inhibitors.
Nomura W; Hashimoto C; Suzuki T; Ohashi N; Fujino M; Murakami T; Yamamoto N; Tamamura H
Bioorg Med Chem; 2013 Aug; 21(15):4452-8. PubMed ID: 23800723
[TBL] [Abstract][Full Text] [Related]
14. A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism.
Pascual R; Moreno MR; Villalaín J
J Virol; 2005 Apr; 79(8):5142-52. PubMed ID: 15795298
[TBL] [Abstract][Full Text] [Related]
15. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
Bär S; Alizon M
J Virol; 2004 Jan; 78(2):811-20. PubMed ID: 14694113
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
Lawless MK; Barney S; Guthrie KI; Bucy TB; Petteway SR; Merutka G
Biochemistry; 1996 Oct; 35(42):13697-708. PubMed ID: 8885850
[TBL] [Abstract][Full Text] [Related]
17. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
[TBL] [Abstract][Full Text] [Related]
18. [Fusion of negatively-charged liposomes under the effect of peptides from the N-terminal fragment of the HIV-1 transmembrane protein].
Terletskaia IaT; Trikash IO; Serdiuk ES; Andreev SM
Biokhimiia; 1995 Oct; 60(10):1711-9. PubMed ID: 8555367
[TBL] [Abstract][Full Text] [Related]
19. The hydrophobic internal region of bovine prion protein shares structural and functional properties with HIV type 1 fusion peptide.
Sáez-Cirión A; Nieva JL; Gallaher WR
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):969-78. PubMed ID: 14678604
[TBL] [Abstract][Full Text] [Related]
20. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
Ferrer M; Kapoor TM; Strassmaier T; Weissenhorn W; Skehel JJ; Oprian D; Schreiber SL; Wiley DC; Harrison SC
Nat Struct Biol; 1999 Oct; 6(10):953-60. PubMed ID: 10504731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
